Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOEX.L Regulatory News (OEX)

  • There is currently no data for OEX

Update on Underwritten Rights Issue

3 Aug 2015 07:51

RNS Number : 8422U
Oilex Ltd
03 August 2015
 



ASX Announcement

 

3 August 2015

 

 

ASX: OEX

AIM: OEX

 

Update on Underwritten Rights Issue

 

Oilex Ltd (Oilex or the Company) is pleased to provide an update on the result of the previously announced Underwritten Rights Issue, and announces changes to the second tranche of the previously announced Placing.

 

As announced on 31 July 2015, 16,235,098 Rights Issue Shares have been taken up by shareholders, resulting in a shortfall in the Rights Issue of 153,241,412 shares. Under the terms of the underwriting agreement in respect of the Rights Issue, and as disclosed in the Company's announcement of 17 July 2015 (paragraph 5.7 of the Offer Booklet), as the share price of Oilex has, during the offer period, fallen below the A$0.041 Rights Issue offer price, a potential termination event has been triggered whereby the underwriter has the right to terminate the underwriting agreement.

 

In light of this development, the Company has taken steps to seek alternative participants for part of the Rights Issue shortfall. Accordingly, Zeta Resources Ltd (Zeta) has agreed to take up 62,011,067 shares by way of placement out of the Rights Issue shortfall at the Offer Price of A$0.041, for a total consideration of approximately A$2.55 million (£1.24 million, US$1.95 million) and will receive a fee of 6% that would otherwise have been paid to the underwriter. On this basis, the underwriter has agreed not to invoke its termination right under the underwriting agreement, and the underwriter (or its nominees) will take up the remaining Rights Issue shortfall.

 

As announced on 7 and 8 July 2015, Zeta's participation in the second tranche of the Placing will be settled in 2 tranches. As a result of Zeta's take up of Rights Issue shortfall shares as outlined above, and in order that it and its associates do not breach relevant Australian takeovers laws (under which, broadly, a person may not acquire shares if that would cause their and their associates' voting power to exceed 20%), Zeta has agreed that its second tranche investment will now proceed as follows (subject to approval of the resolutions proposed at the Company's General Meeting convened for 12 August 2015):

· 50,000,000 new ordinary shares will be placed with Zeta at a price of A$0.041 (2 pence) per share, to be settled immediately following the General Meeting;

· a further 124,019,608 (previously 225,490,196) new ordinary shares will be placed with Zeta at a price of A$0.0418 (2.04 pence) per share, to be settled by no later than 12 November 2015. These shares will be issued out of the authorisation to be sought at the General Meeting (covering 225,490,196 shares); and

· in lieu of the remaining shares originally envisaged to be issued to Zeta, (being 101,470,588 shares) the Company will issue A$4,243,500 (approximately £2.07 million) of 20 year, zero coupon unsecured convertible loan notes to Zeta, which will be convertible into shares at Zeta's option at any time, subject to compliance with Australian law, at a conversion price of A$0.0418 per share. The issue of these convertible notes will occur contemporaneously with the issue to Zeta of the 124,019,608 new ordinary shares referred to above. These convertible notes will be issued pursuant to the Company's placement capacity under Listing Rule 7.1 (as refreshed at the General Meeting). To the extent that the convertible notes are not converted, they will be redeemable on 30 June 2035 or such later date as agreed with Zeta. The Zeta Convertible Notes will have the right to participate in rights issues and other pro-rata issues on an "as converted" basis, subject to compliance with law.

 

 

Upon completion of the Rights Issue and Tranche 2 placing, Zeta and associates will hold approximately 275 million ordinary shares, representing approximately 19.6% of the Company's enlarged share capital (on an undiluted basis). Zeta will also hold A$4,243,500 of unsecured convertible notes, convertible into 101,470,588 ordinary shares.

 

The remaining portion of the second tranche of the Placing will proceed as previously announced and the Placing timetable remains unchanged. Given their relevance to the matters to be considered at the General Meeting, shareholders will be notified of the above changes by letter in the coming days.

 

 Managing Director of Oilex, Ron Miller, said;

"The financial support by Zeta not only in the second tranche, but now the Rights Issue shortfall is very pleasing and demonstrates their commitment to Oilex's business plan. This plan is focussed on production and cashflow from the recently independently assessed Reserves at our Cambay Field in India. We are delighted that the Rights Issue will successfully complete, leading to a General Meeting on 12 August 2015 where shareholders will have the opportunity to approve the second tranche of the Placing."

 

 

 

Yours faithfully,

  

Ron Miller

Managing Director

 

For further information, please contact the company or its advisors listed below:

 

PAC Partners Pty Ltd

Australian Broker

Andrew Shearer

Email: ashearer@pacpartners.com.au

Tel: +61 3 8633 9862

Australia

Westhouse Securities Limited

AIM Broker

Robert Finlay / Alastair Stratton

Email:  alastair.stratton@westhousesecurities.com

Tel: +44 20 7601 6100

UK

 

Strand Hanson Limited

Nominated Adviser

Rory Murphy /Ritchie Balmer

Email:  

oilex@strandhanson.co.uk

Tel: +44 20 7409 3494

UK

 

Vigo Communications

Public Relations UK

Patrick d'Ancona / Chris McMahon

Email:patrick.dancona@vigocomms.com

chris.mcmahon@vigocomms.com

Tel: +44 20 7016 9570

UK

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLIFSRTAIVIIE
Date   Source Headline
31st Jan 20224:41 pmRNSSecond Price Monitoring Extn
31st Jan 20224:36 pmRNSPrice Monitoring Extension
28th Jan 202212:50 pmRNSAppointment of Director
28th Jan 202212:47 pmRNSDecember 2021 Quarterly Report
18th Jan 20227:13 amRNSGM – Notice of Meeting
17th Jan 202212:19 pmRNSPlacing - Issue of Securities
4th Jan 20227:00 amRNSPlacement – Issue of Securities
29th Dec 20212:29 pmRNSChange of Interests of Substantial Holder
23rd Dec 20217:00 amRNSIssue of Securities
22nd Dec 20217:00 amRNSUnmarketable Parcel Facility Update
15th Dec 20218:47 amRNSCambay Production Re-start Update
13th Dec 20213:56 pmRNSCambay Well 77H Re-Frac Funding Secured
30th Nov 20217:00 amRNSUnmarketable Parcel Facility Update
29th Nov 20217:00 amRNSResult of Annual General Meeting
11th Nov 20217:00 amRNSIssue of Shares and Section 708A(5)(e) Notice
29th Oct 202110:40 amRNSAward of Well Management Services Contract
28th Oct 20217:34 amRNSSeptember 2021 Quarterly Report
27th Oct 20217:00 amRNSNotice of AGM
4th Oct 20211:39 pmRNSAGM Date / Closing Date for Director Nominations
28th Sep 20212:06 pmRNSSecond Price Monitoring Extn
28th Sep 20212:00 pmRNSPrice Monitoring Extension
22nd Sep 20213:59 pmRNSCorporate Governance Statement
22nd Sep 20213:59 pmRNSAnnual Report 2021
17th Sep 20214:41 pmRNSSecond Price Monitoring Extn
17th Sep 20214:36 pmRNSPrice Monitoring Extension
17th Sep 202111:13 amRNSCambay Update and UK Exploration Licence P2446
7th Sep 20219:53 amRNSASX Unmarketable Parcel Share Disposal
26th Aug 20217:00 amRNSAppointment of New Company Secretary
12th Aug 20217:01 amRNSAppendix 3Y P Haywood
12th Aug 20217:01 amRNSAppendix 3Y P Schwarz
12th Aug 20217:00 amRNSIssue of Shares and Section 708A(5)(e) Notice
30th Jul 20217:00 amRNSJune 2021 Quarterly Report
21st Jul 20217:24 amRNSAIM Rule 17 Disclosure
2nd Jul 20218:15 amRNSAppointment of New CFO
25th Jun 20217:00 amRNSAppendix 3Y P Schwarz
25th Jun 20217:00 amRNSAppendix 3Y P Haywood
24th Jun 20217:00 amRNSIssue of Securities
22nd Jun 202110:48 amRNSIssue of Securities
21st Jun 202111:19 amRNSIssue of Securities
17th Jun 20218:41 amRNSAppendix 3X Roland Wessel
16th Jun 20218:30 amRNSAppointment of New CEO & Director
10th Jun 202112:05 pmRNSExecution of Cambay SPA
10th Jun 202110:13 amRNSIssue of Securities
8th Jun 20217:00 amRNSResults of General Meeting
7th Jun 20212:05 pmRNSSecond Price Monitoring Extn
7th Jun 20212:00 pmRNSPrice Monitoring Extension
28th May 20217:00 amRNSBhandut Sale Completed
21st May 20217:35 amRNSAppendix 3Y P Schwarz
21st May 20217:34 amRNSAppendix 3Y P Haywood
18th May 20217:00 amRNSGM - Notice of Meeting - Change of Venue

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.